BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1903301)

  • 1. Cost efficiency of bone scans in breast cancer.
    Kennedy H; Kennedy N; Barclay M; Horobin M
    Clin Oncol (R Coll Radiol); 1991 Mar; 3(2):73-7. PubMed ID: 1903301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.
    Yeh KA; Fortunato L; Ridge JA; Hoffman JP; Eisenberg BL; Sigurdson ER
    Ann Surg Oncol; 1995 Jul; 2(4):319-24. PubMed ID: 7552621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal scintigraphy in carcinoma of the breast--a ten year retrospective study of 389 patients.
    Ahmed A; Glynne-Jones R; Ell PJ
    Nucl Med Commun; 1990 Jun; 11(6):421-6. PubMed ID: 2385428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective?
    Wikenheiser KA; Silberstein EB
    Cleve Clin J Med; 1996; 63(1):43-7. PubMed ID: 8590515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A re-evaluation of isotope screening for skeletal metastases in node-negative breast cancer.
    Gudgeon CA; Werner ID; Dent DM
    S Afr Med J; 1996 Feb; 86(2):166-9. PubMed ID: 8619145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Staging of patients with carcinoma of the breast by bone scans? [author's transl)].
    Creutzig H
    Radiologe; 1978 May; 18(5):179-83. PubMed ID: 652985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reevaluation of bone scans in breast cancer.
    Hayward RB; Frazier TG
    J Surg Oncol; 1985 Feb; 28(2):111-3. PubMed ID: 3918216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone scintigraphy in patients with operable breast cancer stages I and II. Final conclusion after five-year follow-up.
    Butzelaar RM; van Dongen JA; de Graaf PW; van der Schoot JB
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):877-80. PubMed ID: 6540189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of bone scan as a screening work-up in primary and local-regional recurrence of breast cancer.
    Khansur T; Haick A; Patel B; Balducci L; Vance R; Thigpen T
    Am J Clin Oncol; 1987 Apr; 10(2):167-70. PubMed ID: 3565316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radionuclide evaluation of skeletal metastases: practical considerations.
    Gold RH; Bassett LW
    Skeletal Radiol; 1986; 15(1):1-9. PubMed ID: 3941915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is staging bone scan useful in patients with small invasive breast carcinoma?].
    Simon E; Marret H; Barillot I; Bougnoux A; Hajjaji N; Body G
    Gynecol Obstet Fertil; 2009 Jan; 37(1):91-4. PubMed ID: 19059802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of bone scanning in the staging of breast cancer.
    Kirkman S; Henk JM
    Clin Radiol; 1979 Jan; 30(1):11-4. PubMed ID: 421415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bone scan in preoperative clinical staging of breast cancer.
    Wilson GS; Rich MA; Brennan MJ
    Arch Surg; 1980 Apr; 115(4):415-9. PubMed ID: 7362447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of serial bone scanning in operable breast cancer.
    Monypenny IJ; Grieve RJ; Howell A; Morrison JM
    Br J Surg; 1984 Jun; 71(6):466-8. PubMed ID: 6722488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of baseline and follow-up whole-body bone scans in detecting bone metastasis in high-risk breast cancer patients.
    Al-Muqbel KM; Yaghan RJ
    Nucl Med Commun; 2013 Jun; 34(6):577-81. PubMed ID: 23542913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of follow-up bone scans in the management of postoperative breast cancer--when should it be performed?].
    Suzuki T; Watarai J; Ohgushi M; Adachi M; Yamaguchi K
    Gan No Rinsho; 1987 Sep; 33(11):1314-7. PubMed ID: 3669318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoblastic metastases from breast carcinoma with false-negative bone scan.
    Munk PL; Poon PY; O'Connell JX; Janzen D; Coupland D; Kwong JS; Gelmon K; Worsley D
    Skeletal Radiol; 1997 Jul; 26(7):434-7. PubMed ID: 9259104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of radionuclide bone scanning and liver ultrasonography for staging breast cancer.
    Cox MR; Gilliland R; Odling-Smee GW; Spence RA
    Aust N Z J Surg; 1992 Jul; 62(7):550-5. PubMed ID: 1610323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the number of bone scan abnormalities at the time of initial bone metastatic recurrence in breast carcinoma.
    Jacobson AF; Shapiro CL; Van den Abbeele AD; Kaplan WD
    Cancer; 2001 Jan; 91(1):17-24. PubMed ID: 11148555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.